EZZ Life Science’s Director Qizhou Qin Increases Shareholding

EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.

EZZ Life Science Holdings Ltd. has reported a change in the securities interests of director Qizhou Qin, with the acquisition of 90,830 fully paid ordinary shares through an on-market trade. The transaction, carried out between December 9 and 11, 2024, was priced between $2.52 and $2.71 per share. This adjustment reflects Qin’s continued investment in the company’s growth.

For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.